ECU
MRNA icon

Eisler Capital (US)’s Moderna MRNA Stock Holding History

Eisler Capital (US)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,187
Closed -$752K – 601
2024
Q2 		$972K Buy
+8,187
New +$1.04M 0.02% 444

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eisler Capital (US)'s MRNA Position: Q3 2024 in Review

Eisler Capital (US) sold out of Moderna (MRNA) in Q3 2024, closing a stake of 8,187 shares — an estimated $752K sold.

Eisler Capital (US) first reported a position in MRNA in Q2 2024 and held it in 1 quarter. The position peaked at $972K in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Eisler Capital (US) reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 8,187 Moderna shares in Q3 2024, an estimated $752K.
  • Eisler Capital (US) first reported a position in Moderna in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Moderna position peaked at $972K in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.